Real-world outcomes after Mirvetuximab Soravtansine treatment for recurrent ovarian Cancer: Results from a university setting
Listen to this summary
The authors aimed to evaluate the real-world effectiveness and toxicity of Mirvetuximab Soravtansine (MIRV) in patients with recurrent ovarian cancer, as previous trials had stringent eligibility criteria. In a retrospective analysis of 66 patients, they found a median overall survival of 16.4 months and a progression-free survival of 5.3 months, with performance status significantly impacting survival outcomes. The study highlights the common occurrence of toxicity and the need for careful management, particularly in patients with poorer performance status.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from Gynecologic oncology reports
View all →Sep 23, 2026 · Gynecologic oncology reports
Fertility-sparing surgery for a patient with a pre-operative suspected diagnosis of a Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A case report
Sep 23, 2026 · Gynecologic oncology reports
Trabectedin plus pegylated liposomal doxorubicin in recurrent ovarian carcinoma after poly-ADP-ribose polymerase inhibitors progression: A real-world single-center experience
Sep 23, 2026 · Gynecologic oncology reports
Abscopal effect following palliative radiotherapy after cemiplimab in recurrent cervical cancer: a case report
Sep 20, 2026 · Gynecologic oncology reports
Temozolomide and olaparib for the treatment of an ARID1A-mutated uterine carcinosarcoma: A case report
Sep 12, 2026 · Gynecologic oncology reports
Markedly elevated alpha-fetoprotein leading to the diagnosis of high-grade endometrial carcinoma during hepatocellular carcinoma surveillance
Sep 5, 2026 · Gynecologic oncology reports
Molecular subtypes of stage III vulvar squamous cell carcinoma predict recurrence and survival outcomes
More in Obstetrics & Gynecology
View all →Sep 23, 2026 · International urogynecology journal
Comparison of Postoperative Functional Recovery and Anatomical Restoration in Patients with Pelvic Organ Prolapse Undergoing Three Types of Apical Suspension Techniques: A Retrospective Study
Sep 23, 2026 · Prenatal diagnosis
Curating the Fetal Genome: Experience of the ClinGen Prenatal Gene Curation Expert Panel (GCEP)
Sep 23, 2026 · Human reproduction (Oxford, England)
Maternal TRIM28 safeguards bovine embryonic genome activation by regulating SAM-dependent methylation via lipid metabolism
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · O&G open
Electronic Consultation-Driven Penicillin Allergy Delabeling in Pregnancy
Sep 23, 2026 · International urogynecology journal
The Surgical Challenge of the Repeat Sacrocolpopexy
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
